These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Treatment of hyaline membrane disease by administration of exogenous surfactant]. Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F. Arch Fr Pediatr; 1985 May; 42(5):397-402. PubMed ID: 3907577 [No Abstract] [Full Text] [Related]
47. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants]. Saule H. Med Klin; 1975 Mar 07; 70(10):409-15. PubMed ID: 1091827 [No Abstract] [Full Text] [Related]
48. [High-frequency oscillatory lung ventilation in complex therapy for congenital pneumonia and hyaline membrane disease in newborns]. Antonov AG, Ionov OV, Burkova AS. Anesteziol Reanimatol; 2005 Mar 07; (1):41-4. PubMed ID: 15839224 [Abstract] [Full Text] [Related]
49. What is new in our understanding of perinatal pulmonary problems? Presidential address to the Society for Pediatric Research, May 19, 1973. Avery ME. Pediatr Res; 1973 Oct 07; 7(10):842-5. PubMed ID: 4583722 [No Abstract] [Full Text] [Related]
50. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model. Maeta H, Raju TN, Vidyasagar D, Bhat R, Esterly J, Matsuda H, Shimada S, Krukenkamp IB, Shanklin DR. Crit Care Med; 1990 Apr 07; 18(4):403-9. PubMed ID: 2318051 [Abstract] [Full Text] [Related]
51. Resuscitation and respiratory management of infants weighing less than 1000 grams. Bhat R, Zikos-Labropoulou E. Clin Perinatol; 1986 Jun 07; 13(2):285-97. PubMed ID: 3755084 [Abstract] [Full Text] [Related]
52. Surfactant replacement in neonatal and adult respiratory distress syndrome. Robertson B. Eur J Anaesthesiol; 1984 Dec 07; 1(4):335-43. PubMed ID: 6549536 [Abstract] [Full Text] [Related]
53. [Recent acquisitions in hyaline membrane disease]. Bona G, Mussa GC. Minerva Med; 1977 Aug 04; 68(37):2567-74. PubMed ID: 331143 [Abstract] [Full Text] [Related]
55. [Lung insufficiency in neonatal period]. Saugstad OD. Tidsskr Nor Laegeforen; 1982 Mar 30; 102(9-10):546-51. PubMed ID: 6897590 [No Abstract] [Full Text] [Related]
56. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease]. Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME. Bol Med Hosp Infant Mex; 1993 Jul 30; 50(7):481-91. PubMed ID: 8363747 [Abstract] [Full Text] [Related]
57. Treatment of severe hyaline membrane disease with surfactant (Curosurf). A collaborative clinical study. Büky B, Dévai G, Várady E, Rózsavölgyi A, Kovách I, Kovács A, Jancsó G, Waldinger K, Görgényi A, Zsolnai B. Acta Paediatr Hung; 1990 Jul 30; 30(3-4):351-65. PubMed ID: 2083097 [Abstract] [Full Text] [Related]
58. The pulmonary surfactant. Sekabunga JG. East Afr Med J; 1973 Jan 30; 50(1):27-32. PubMed ID: 4578486 [No Abstract] [Full Text] [Related]
59. [The fate of hyaline membranes in the lungs of adults after artificial respiration]. Macha HN, Masshoff W. Beitr Pathol; 1972 Jan 30; 145(4):365-80. PubMed ID: 5067278 [No Abstract] [Full Text] [Related]